# US 2009/0270433 A1 · 2,3-dihydro-iminoisoindole derivatives

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2009/0270433 A1
- Document ID: US20090270433A1
- Status: Published application
- Kind: A1
- Application number: 12/234,116
- Filed: 2008-09-19
- Published: 2009-10-29
- Earliest claimed: 2007-09-21
- Assignees: Eisai R&D Management Co., Ltd.
- Inventors: Richard Clark; Atsushi Takemura; Nobuhisa Watanabe; Osamu Asano; Tadashi Nagakura; Kimlyo Tabata
- Web page: https://patentgrep.com/patent/US20090270433A1

## CPC

- C07D 417/14: containing three or more hetero rings
- A61P 7/02: Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A61P 9/10: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A61P 9/14: Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
- A61P 11/00: Drugs for disorders of the respiratory system
- A61P 35/00: Antineoplastic agents
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07D 209/44: Iso-indoles; Hydrogenated iso-indoles
- C07D 401/12: linked by a chain containing hetero atoms as chain links
- C07D 401/14: containing three or more hetero rings
- C07D 403/14: containing three or more hetero rings
- C07D 405/14: containing three or more hetero rings
- C07D 409/14: containing three or more hetero rings
- C07D 413/14: containing three or more hetero rings
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

A compound represented by the following general formula (1), or a salt thereof has serine protease inhibiting activity, and particularly excellent inhibiting activity against clotting factor VIIa. This compound or a salt thereof is useful as therapeutic and/or prophylactic agents for diseases associated with thrombus formation. [wherein R1 represents hydrogen, R2 represents optionally substituted phenyl, etc., R3 represents optionally substituted C6-10 aryl, etc.]

## Claims

### Claim 1

A compound represented by general formula (I), or a salt thereof:
wherein R1 represents hydrogen;
R2 represents a C6-10 aryl optionally having 1-5 substituents selected from Group A1 below, a 5- to 10-membered heteroaryl group optionally having 1-5 substituents selected from Group A1 below or a 9- to 12-membered benzene-fused cyclic group optionally having 1-5 substituents selected from Group A1 below; and
R3 represents a 5- or 6-membered non-aromatic heterocyclic group optionally having 1-5 substituents selected from Group A1 below, a C6-10 aryl optionally having 1-5 substituents selected from Group A1 below or a 5- to 10-membered heteroaryl group optionally having 1-5 substituents selected from Group A1 below,
wherein Group A1 consists of hydroxyl, halogen, cyano, nitro, oxo, C1-6 alkyl optionally having 1-3 substituents selected from Group B1 below, C3-8 cycloalkyl optionally having 1-5 substituents selected from Group B1 below, C2-6 alkenyl, C2-6 alkynyl, C1-6 alkoxy optionally having 1-3 substituents selected from Group B1 below, C3-8 cycloalkyloxy optionally having 1-5 substituents selected from Group B1 below, C2-6 alkenyloxy, C2-6 alkynyloxy, C1-6 alkylthio, C1-6 alkylsulfinyl, C1-6 alkylsulfonyl, C1-6 alkylsulfonyloxy, C6-10 aryl optionally having 1-5 substituents selected from Group B1 below, C6-10 aryloxy optionally having 1-5 substituents selected from Group B1 below, 5- to 10-membered heteroaryl group optionally having 1-5 substituents selected from Group B1 below, 5- to 10-membered heteroaryloxy optionally having 1-5 substituents selected from Group B1 below, a 5- or 6-membered non-aromatic heterocyclic group optionally having 1-5 substituents selected from Group B1 below, 5- or 6-membered non-aromatic heterocyclooxy optionally having 1-5 substituents selected from Group B1 below, a group represented by —NR1t—R2t and a group represented by —CO—R3t;
where R1t and R2t each independently represent hydrogen, C1-6 alkyl optionally having 1-3 substituents selected from Group B1 below, C2-6 alkenyl, C2-7 alkylcarbonyl optionally having 1-3 substituents selected from Group B1 below, C2-7 alkoxycarbonyl optionally having 1-3 substituents selected from Group B1 below, C1-6 alkylsulfonyl optionally having 1-3 substituents selected from Group B1 below, carbamoyl, aminosulfonyl, C6-10 aryl optionally having 1-5 substituents selected from Group B1 below or 5- to 10-membered heteroaryl group optionally having 1-5 substituents selected from Group B1 below, and
R3t represents hydroxyl, C1-6 alkyl optionally having 1-3 substituents selected from Group B1 below, C1-6 alkoxy optionally having 1-3 substituents selected from Group B1 below, amino, mono(C1-6 alkyl)amino optionally having 1-3 substituents selected from Group B1 below or di(C1-6 alkyl)amino optionally having 1-3 substituents selected from Group B1 below,
wherein Group B1 consists of hydroxyl, halogen, cyano, oxo, C1-6 alkoxy optionally having halogen, C3-8 cycloalkyl, amino, mono(C1-6 alkyl)amino, di(C1-6 alkyl)amino, carbamoyl, mono(C1-6 alkyl)aminocarbonyl, di(C1-6 alkyl)aminocarbonyl, C6-10 aryl optionally having 1-5 substituents selected from Group C1 below, and 5- to 10-membered heteroaryl group optionally having 1-5 substituents selected from Group C1 below,
wherein Group C1 consists of halogen, C1-6 alkyl and C1-6 alkoxy.

### Claim 2 (depends on 1)

A compound represented by general formula (1-1), or a salt thereof:
wherein R1, R2 and R3 have the same definitions as R1, R2 and R3 in claim 1.

### Claim 3 (depends on 1)

A compound represented by general formula (1-2), or a salt thereof:
wherein R1, R2 and R3 have the same definitions as R1, R2 and R3 in claim 1.

### Claim 4 (depends on 1)

A compound represented by the following general formula, or a salt thereof:
wherein R2 and R3 have the same definitions as R2 and R3 in claim 1;
M1 represents hydrogen or C1-6 alkyl; M2 represents hydrogen or C1-6 alkyl; M3 represents a single bond, —SO2—, —CO— or —CS—;
Q1 represents hydrogen or C1-6 alkyl; Q2 represents morpholino or a group represented by the following formula:
wherein Q5 represents hydrogen or C1-6 alkyl, and Q3 and Q4 each independently represent methyne or nitrogen,
where Q2 optionally has 1-3 substituents selected from Group A1 in claim 1;
K1 represents methylene or carbonyl; K2 represents hydrogen or C1-6 alkyl;
G1 represents a 5- to 10-membered heterocyclic group selected from the following Group G1: Group G1 is the group consisting of furyl, thienyl, pyrolyl, imidazolyl, triazolyl, tetrazolyl, thiazolyl, pyrazolyl, oxazolyl, isooxazolyl, isothiazolyl, furazanyl, thiadiazolyl, oxadiazolyl, pyridyl, pyrazinyl, pyridazinyl, pyrimidinyl, triazinyl, purinyl, pteridinyl, quinolyl, isoquinolyl, naphthylidinyl, quinoxalinyl, cinnolinyl, quinazolinyl, phthaladinyl, imidazopyridyl, imidazothiazolyl, imidazooxazolyl, benzothiazolyl, benzooxazolyl, benzoimidazolyl, indolyl, isoindolyl, indazolyl, pyrrolopyridyl, thienopyridyl, furopyridyl, benzothiadiazolyl, benzooxadiazolyl, pyridopyrimidinyl, benzofuryl, benzothienyl, benzo[1,3]dioxole, thienofuryl, N-oxypyridyl, N—C1-6 alkylpyridinium, 5,6,7,8-tetrahydro quinolyl and 4,5,6,7-tetrahydro-1H-benzo[d]imidazolyl.

### Claim 5 (depends on 1)

A compound or a salt thereof according to claim 1, wherein R2 is phenyl optionally having 1-4 substituents selected from Group D1 below, pyridyl optionally having 1-3 substituents selected from Group D1 below or a 9- to 12-membered benzene-fused cyclic group optionally having 1-4 substituents selected from Group D1 below,
wherein Group D1 consists of hydroxyl, halogen, C1-6 alkyl optionally having 1-3 substituents selected from Group D2 below, C2-6 alkenyl, C2-6 alkynyl, C1-6 alkoxy optionally having 1-3 substituents selected from Group D2 below, C2-6 alkenyloxy, C1-6 alkylsulfonyloxy, 5- or 6-membered non-aromatic heterocyclooxy optionally having 1-3 substituents selected from Group D2 below and C2-7 alkylcarbonyl,
wherein Group D2 consists of hydroxyl, halogen, cyano, oxo, C1-6 alkoxy optionally having halogen, mono(C1-6 alkyl)amino, di(C1-6 alkyl)amino, mono(C1-6 alkyl)aminocarbonyl and di(C1-6 alkyl)aminocarbonyl.

### Claim 6 (depends on 1)

A compound or a salt thereof according to claim 1, wherein R2 is phenyl optionally having 1-4 substituents selected from Group D1 below,
wherein Group D1 consists of hydroxyl, halogen, C1-6 alkyl optionally having 1-3 substituents selected from Group D2 below, C2-6 alkenyl, C2-6 alkynyl, C1-6 alkoxy optionally having 1-3 substituents selected from Group D2 below, C2-6 alkenyloxy, C1-6 alkylsulfonyloxy, 5- or 6-membered non-aromatic heterocyclooxy optionally having 1-3 substituents selected from Group D2 below and C2-7 alkylcarbonyl,
wherein Group D2 consists of hydroxyl, halogen, cyano, oxo, C1-6 alkoxy optionally having halogen, mono(C1-6 alkyl)amino, di(C1-6 alkyl)amino, mono(C1-6 alkyl)aminocarbonyl and di(C1-6 alkyl)amino carbonyl.

### Claim 7 (depends on 1)

A compound or a salt thereof according to claim 1, wherein R2 is phenyl optionally having 2 or 3 substituents selected from Group D3 below,
wherein Group D3 consists of fluorine, chlorine, methyl optionally having 1 substituent selected from Group D4 below, ethyl optionally having 1 substituent selected from Group D4 below, vinyl, ethynyl, methoxy optionally having 1 or 2 substituents selected from Group D4 below, ethoxy optionally having 1 or 2 substituents selected from Group D4 below, 1-propyloxy optionally having 1 or 2 substituents selected from Group D4 below, 2-propyloxy optionally having 1 or 2 substituents selected from Group D4 below, allyloxy, tetrahydrofuryloxy, tetrahydropyranyloxy and acetyl,
wherein Group D4 consists of hydroxyl, fluorine, cyano, methoxy, methyl amino, dimethylamino, methylaminocarbonyl and dimethylaminocarbonyl.

### Claim 8 (depends on 1)

A compound or a salt thereof according to claim 1, wherein R2 is a group represented by the following formula:
wherein R21 represents hydrogen, benzyloxy, fluorine or chlorine;
R22 represents hydrogen, hydroxyl, methyl optionally having 1 substituent selected from Group D5 below, ethyl optionally having 1 substituent selected from Group D5 below, methoxy optionally having 1 substituent selected from Group D5 below, ethoxy optionally having 1 or 2 substituents selected from Group D5 below, 1-propyloxy optionally having 1 substituent selected from Group D5 below, 2-propyloxy optionally having 1 substituent selected from Group D5 below, allyloxy, tetrahydrofuryloxy, tetrahydropyranyloxy or acetyl;
R23 represents hydrogen, fluorine, hydroxyl, methoxy optionally having 1 substituent selected from Group D6 below, ethoxy optionally having 1 substituent selected from Group D6 below or 2-propyloxy optionally having 1 substituent selected from Group D6 below; and
R24 represents hydrogen, fluorine, hydroxyl, methyl optionally having 1 substituent selected from Group D7 below, ethyl, vinyl, ethynyl, methoxy optionally having 1 substituent selected from Group D7 below, ethoxy optionally having 1 substituent selected from Group D7 below, 2-propyloxy or allyloxy,
wherein Group D5 consists of hydroxyl, fluorine, cyano, methoxy, dimethylamino, dimethylaminocarbonyl, 2-fluoroethoxy and 2-hydroxyethoxy,
wherein Group D6 consists of fluorine, cyano, methoxy, dimethylamino, methylaminocarbonyl and dimethylaminocarbonyl,
wherein Group D7 consists of hydroxyl, fluorine, cyano and ethoxy having one methoxy.

### Claim 9 (depends on 8)

A compound or a salt thereof according to claim 8, wherein R21 is hydrogen or fluorine.

### Claim 10 (depends on 8)

A compound or a salt thereof according to claim 8, wherein R22 is hydrogen, hydroxyl, cyanomethyl, methoxymethyl, methoxy, dimethylaminocarbonylmethoxy, ethoxy, 2-fluoroethoxy, 2-hydroxyethoxy, 2-methoxyethoxy, 2-(dimethylamino)ethoxy, tetrahydrofuryloxy, tetrahydropyranyloxy, fluoromethoxy, 3-hydroxypropyloxy, 2-fluoroethoxymethyl or 2-hydroxyethoxymethyl.

### Claim 11 (depends on 8)

A compound or a salt thereof according to claim 8, wherein R23 is hydrogen, fluorine, methoxy, cyanomethoxy, ethoxy, 2-propyloxy or 2-methoxyethoxy.

### Claim 12 (depends on 8)

A compound or a salt thereof according to claim 8, wherein R24 is hydrogen, hydroxyl, methyl, methoxymethyl, ethyl, vinyl, ethynyl, methoxy, ethoxy or 2-fluoroethoxy.

### Claim 13 (depends on 1)

A compound or a salt thereof according to claim 1, wherein R2 is pyridyl optionally having 1-3 substituents selected from Group D1 below,
wherein Group D1 consists of hydroxyl, halogen, C1-6 alkyl optionally having 1-3 substituents selected from Group D2 below, C2-6 alkenyl, C2-6 alkynyl, C1-6 alkoxy optionally having 1-3 substituents selected from Group D2 below, C2-6 alkenyloxy, C1-6 alkylsulfonyloxy, 5- or 6-membered non-aromatic heterocyclooxy optionally having 1-3 substituents selected from Group D2 below and C2-7 alkylcarbonyl,
wherein Group D2 consists of hydroxyl, halogen, cyano, oxo, C1-6 alkoxy optionally having halogen, mono(C1-6 alkyl)amino, di(C1-6 alkyl)amino, mono(C1-6 alkyl)aminocarbonyl and di(C1-6 alkyl)aminocarbonyl.

### Claim 14 (depends on 1)

A compound or a salt thereof according to claim 1, wherein R2 is pyridyl having two substituents selected from the group consisting of C1-6 alkyl and C1-6 alkoxy.

### Claim 15 (depends on 1)

A compound or a salt thereof according to claim 1, wherein R2 is pyridyl having two substituents selected from the group consisting of methyl, methoxy and ethoxy.

### Claim 16 (depends on 1)

A compound or a salt thereof according to claim 1, wherein R2 is a group represented by the following formula:
wherein R25 is methyl or methoxy, and R26 is methoxy or ethoxy.

### Claim 17 (depends on 1)

A compound or a salt thereof according to claim 1, wherein R2 is a 9- to 12-membered benzene-fused cyclic group optionally having 1-4 substituents selected from Group D1 below,
wherein Group D1 consists of hydroxyl, halogen, C1-6 alkyl optionally having 1-3 substituents selected from Group D2 below, C2-6 alkenyl, C2-6 alkynyl, C1-6 alkoxy optionally having 1-3 substituents selected from Group D2 below, C2-6 alkenyloxy, C1-6 alkylsulfonyloxy, 5- or 6-membered non-aromatic heterocyclooxy optionally having 1-3 substituents selected from Group D2 below and C2-7 alkylcarbonyl,
wherein Group D2 consists of hydroxyl, halogen, cyano, oxo, C1-6 alkoxy optionally having halogen, mono(C1-6 alkyl)amino, di(C1-6 alkyl)amino, mono(C1-6 alkyl)aminocarbonyl and di(C1-6 alkyl)aminocarbonyl.

### Claim 18 (depends on 1)

A compound or a salt thereof according to claim 1, wherein R2 is a group represented by the following formula:
wherein R27 represents hydrogen or halogen;
R28 represents hydrogen, hydroxyl, halogen, C1-6 alkyl optionally having 1-3 substituents selected from Group D8 below, C2-6 alkenyl, C2-6 alkynyl, C1-6 alkoxy optionally having 1-3 substituents selected from Group D8 below, or C2-7 alkylcarbonyl;
R29 represents hydrogen, cyano, C1-6 alkyl optionally having 1-3 substituents selected from Group D8 below, C1-6 alkoxy optionally having 1-3 substituents selected from Group D8 below or carbamoyl;
X represents carbon optionally having 1 or 2 substituents selected from Group D8 below, nitrogen optionally having 1 substituent selected from Group D8 below or oxygen;
m represents an integer from 0 to 3 and n represents an integer from 0 to 2, with the proviso that the sum of m and n is 1-4; and
Rings A and B optionally contain one double bond in the ring and optionally have an oxo group on the ring,
wherein Group D8 consists of hydrogen, hydroxyl, halogen, C1-6 alkoxy, mono(C1-6 alkyl)amino, di(C1-6 alkyl)amino, mono(C1-6 alkyl)aminocarbonyl, di(C1-6 alkyl)aminocarbonyl and C1-6 alkyl optionally having halogen.

### Claim 19 (depends on 18)

A compound or a salt thereof according to claim 18, wherein R2 is a group represented by the following formula:
wherein R27 represents hydrogen or halogen;
R28 represents hydrogen, hydroxyl, C1-6 alkyl optionally having 1-3 substituents selected from Group D8 below, C2-6 alkenyl, C2-6 alkynyl, C1-6 alkoxy optionally having 1-3 substituents selected from Group D8 below or C2-7 alkylcarbonyl;
R29 represents hydrogen, cyano, C1-6 alkyl optionally having 1-3 substituents selected from Group D8 below, C1-6 alkoxy optionally having 1-3 substituents selected from Group D8 below or aminocarbonyl; and Ring A optionally has an oxo group on the ring,
wherein Group D8 consists of hydrogen, hydroxyl, halogen, C1-6 alkoxy, mono(C1-6 alkyl)amino, di(C1-6 alkyl)amino, mono(C1-6 alkyl)aminocarbonyl, di(C1-6 alkyl)aminocarbonyl and C1-6 alkyl optionally having halogen.

### Claim 20 (depends on 19)

A compound or a salt thereof according to claim 19, wherein R28 is methyl, ethyl, methoxy, ethoxy, vinyl or ethynyl.

### Claim 21 (depends on 19)

A compound or a salt thereof according to claim 19, wherein R29 is hydrogen.

### Claim 22 (depends on 1)

A compound or a salt thereof according to claim 1, wherein R3 is phenyl optionally having 1-3 substituents selected from Group E1 below, pyridyl optionally having 1-3 substituents selected from Group E1 below, N-oxypyridyl optionally having 1-3 substituents selected from Group E1 below, N—C1-6 alkylpyridinium optionally having 1-3 substituents selected from Group E1 below, pyrazinyl optionally having 1-3 substituents selected from Group E1 below, pyridazinyl optionally having 1-3 substituents selected from Group E1 below, pyrimidinyl optionally having 1-3 substituents selected from Group E1 below, pyrazolyl optionally having 1 or 2 substituents selected from Group E1 below, imidazolyl optionally having 1 or 2 substituents selected from Group E1 below, thiazolyl optionally having 1 or 2 substituents selected from Group E1 below, thienyl optionally having 1-3 substituents selected from Group E1 below, oxazolyl optionally having 1-3 substituents selected from Group E1 below or dihydropyrazinyl having an oxo group, with the proviso that when R3 is N—C1-6 alkylpyridinium, R3 forms an ion pair with an anion in the molecule,
wherein Group E1 consists of hydroxyl, halogen, cyano, C1-6 alkyl, C1-6 alkoxy, a group represented by the formula —NH—R21t and a group represented by the formula —CO—R31t;
where R21t represents hydrogen, C1-6 alkyl, C2-6 alkenyl, C2-7 alkylcarbonyl optionally having 1-3 substituents selected from Group E2 below, C2-7 alkoxycarbonyl optionally having 1-3 substituents selected from Group E2 below, C1-6 alkylsulfonyl, carbamoyl or aminosulfonyl, and
R31t represents hydroxyl, C1-6 alkyl, C1-6 alkoxy, amino, mono(C1-6 alkyl)amino or di(C1-6 alkyl)amino,
wherein Group E2 consists of hydroxyl, C1-6 alkoxy and C3-8 cycloalkyl.

### Claim 23 (depends on 1)

A compound or a salt thereof according to claim 1, wherein R3 is phenyl optionally having 1 or 2 substituents selected from Group E3 below, pyridyl optionally having 1 or 2 substituents selected from Group E3 below, N-oxypyridyl optionally having 1 or 2 substituents selected from Group E3 below, pyrazinyl optionally having 1 or 2 substituents selected from Group E3 below, pyridazinyl optionally having 1 or 2 substituents selected from Group E3 below, pyrimidinyl optionally having 1 or 2 substituents selected from Group E3 below, pyrazolyl optionally having 1 or 2 substituents selected from Group E3 below, imidazolyl optionally having 1 or 2 substituents selected from Group E3 below, thiazolyl optionally having 1 or 2 substituents selected from Group E3 below, thienyl optionally having 1 or 2 substituents selected from Group E3 below, oxazolyl optionally having 1 or 2 substituents selected from Group E3 below or dihydropyrazinyl having an oxo group,
wherein Group E3 consists of halogen, C1-6 alkyl, C1-6 alkoxy, a group represented by the formula —NH—R22t, nitro and a group represented by the formula —CO—R32t;
where R22t is hydrogen or C2-7 alkoxycarbonyl, and R32t is hydroxyl, C1-6 alkoxy or amino.

### Claim 24 (depends on 1)

A compound or a salt thereof according to claim 1, wherein R3 is phenyl optionally having one group selected from Group E4 below, pyridyl optionally having one group selected from Group E5 below, N-oxypyridyl, pyrazinyl, pyridazinyl, pyrimidinyl, pyrazolyl optionally having one group selected from Group E4 below, imidazolyl optionally having one group selected from Group E4 below, thiazolyl optionally having one group selected from Group E4 below, thienyl optionally having one group selected from Group E4 below, oxazolyl optionally having one group selected from Group E4 below or dihydropyrazinyl having an oxo group,
wherein Group E4 consists of methoxy, a group represented by the formula —NH—R22t, nitro, carboxyl, carbamoyl, methoxycarbonyl and methoxycarbonylamino,
where R22t is hydrogen or C2-7 alkoxycarbonyl,
wherein Group E5 consists of fluorine, methyl, methoxy and amino.

### Claim 25 (depends on 1)

A medicament comprising a compound or a salt thereof according to claim 1.

### Claim 26 (depends on 1)

A therapeutic and/or prophylactic agent for a disease associated with thrombus formation, which comprises a compound or a salt thereof according to claim 1.

### Claim 27 (depends on 1)

A therapeutic and/or prophylactic agent for a disease selected from Group F1 below, which comprises a compound or a salt thereof according to claim 1,
wherein Group F1 consists of thrombosis, deep vein thrombosis, pulmonary embolism, cerebral infarction, myocardial infarction, acute coronary syndrome, vascular restenosis, disseminated intravascular coagulation syndrome and malignant tumor.

### Claim 28 (depends on 1)

A therapeutic and/or prophylactic agent for a disease selected from Group F2 below, which comprises a compound or a salt thereof according to claim 1,
wherein Group F2 consists of thrombosis, deep vein thrombosis, pulmonary embolism, cerebral infarction, myocardial infarction, acute coronary syndrome, vascular restenosis and disseminated intravascular coagulation syndrome.

### Claim 29 (depends on 1)

A compound represented by the following general formula (1-3), or a salt thereof:
wherein R2 has the same definition as R2 in claim 1.

### Claim 30 (depends on 1)

A compound represented by the following general formula (1-4), or a salt thereof:
wherein R2 and R3 have the same definitions as R2 and R3 in claim 1;
M1 represents hydrogen or C1-6 alkyl;
M2 represents hydrogen or C1-6 alkyl; and
M3 represents a single bond, —SO2—, —CO— or —CS—.

### Claim 31 (depends on 1)

A compound represented by the following general formula (1-5), or a salt thereof:
wherein R2 has the same definition as R2 in claim 1;
Q1 represents hydrogen or C1-6 alkyl; and
Q2 represents morpholino or a group represented by the following formula:
wherein Q5 represents hydrogen or C1-6 alkyl, and Q3 and Q4 each independently represent methyne or nitrogen,
where Q2 optionally has 1-3 substituents selected from Group A1 in claim 1.

### Claim 32 (depends on 1)

A compound represented by the following general formula (1-6), or a salt thereof:
wherein R2 and R3 have the same definitions as R2 and R3 in claim 1, K1 represents methylene or carbonyl and K2 represents hydrogen or C1-6 alkyl.

### Claim 33 (depends on 1)

A compound represented by the following general formula (1-8), or a salt thereof:
wherein R2 and R3 have the same definitions as R2 and R3 in claim 1 and G1 represents a 5- to 10-membered heterocyclic group selected from the following Group G1: Group G1 is the group consisting of furyl, thienyl, pyrolyl, imidazolyl, triazolyl, tetrazolyl, thiazolyl, pyrazolyl, oxazolyl, isooxazolyl, isothiazolyl, furazanyl, thiadiazolyl, oxadiazolyl, pyridyl, pyrazinyl, pyridazinyl, pyrimidinyl, triazinyl, purinyl, pteridinyl, quinolyl, isoquinolyl, naphthylidinyl, quinoxalinyl, cinnolinyl, quinazolinyl, phthaladinyl, imidazopyridyl, imidazothiazolyl, imidazooxazolyl, benzothiazolyl, benzooxazolyl, benzoimidazolyl, indolyl, isoindolyl, indazolyl, pyrrolopyridyl, thienopyridyl, furopyridyl, benzothiadiazolyl, benzooxadiazolyl, pyridopyrimidinyl, benzofuryl, benzothienyl, benzo[1,3]dioxole, thienofuryl, N-oxypyridyl, N—C1-6 alkylpyridinium, 5,6,7,8-tetrahydroquinolyl and 4,5,6,7-tetrahydro-1H-benzo[d]imidazolyl.
